In a previous study on the role of PROS1 in developing resistance to androgen deprivation therapy, Peng et al. found that high PROS1 expression promoted the proliferation of prostate cancer cells and exacerbated resistance [31]. This evidence concerns the gene PROS1 and prostate carcinoma.